Free Newsletter
Register for our Free Newsletters
Analysis, Inspection and Laboratory
Assisted/Independent Living
Clinical and Nursing Equipment
Design and Manufacture of Medical Equipment
Diagnostics Equipment, Monitoring and Test
Education, Training and Professional Services
Health Education and Patient Management
Health Estates Management
Healthcare Support and Information Services
Hygiene and Infection Control
IT and Communications in Healthcare
Medical Device Technology
Research and Development
Safety and Security
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone

GE Healthcare shows dose reduction improvements for diagnostic cardiac and neuro perfusion CT exams

GE Healthcare : 10 December, 2007  (New Product)
GE Healthcare’s CT technology is offering improved dose reduction results for both diagnostic cardiac and neuro perfusion CT exams.
GE’s SnapShot Pulse is used for prospectively gated diagnostic cardiac CT exams and has been proven to reduce a patient’s radiation exposure by up to 83 percent and improve image quality. The results have been validated from clinicians performing thousands of exams at sites around the world.

GE’s innovative VolumeShuttle technology delivers twice the anatomical coverage (80mm) with up to 24 percent less radiation exposure compared to a conventional 40mm cine perfusion protocol. The single injection acquisition generates clinically comparable perfusion maps and angiographic studies and allows clinicians to see more anatomy and enables whole organ anatomical and physiological assessment.

Both SnapShot Pulse and VolumeShuttle are offered on the GE LightSpeed VCT XT configuration, enabled by a real-time scan control architecture that ensures precise control of exposure and table position.

”We are excited that nearly 200 customers have already selected these innovative technologies as part of a new system or as an in-room upgrade for their existing system,” said Gene Saragnese, vice president of Molecular Imaging and CT for GE Healthcare. “They continue to independently validate that SnapShot Pulse and VolumeShuttle deliver substantial dose reduction while maintaining or improving image quality for routine imaging, case after case.”

Dr Richard Kane, interventional radiologist with Saint Francis Hospital-Resurrection Health Care in Evanston, Illinois, uses these innovative capabilities to detect coronary and vascular disease or trauma in nearly every patient referred to him. “I’ve been routinely impressed with the capabilities presented,” Dr Kane observed. “In this field, most cases intrinsically benefit from the speed, image quality, perfusion coverage and dose reduction afforded by SnapShot Pulse and VolumeShuttle. They have truly become irreplaceable tools for our facility.”

“As leaders in CT, GE has focused on developing technologies that provide clinical excellence and outstanding image quality while reducing dose exposure for patients,” said Saragnese. “We believe this is an important advancement toward realizing GE’s goal of ‘early health’, shifting the paradigm from treating late stage disease to preventing it through early detection.”
Bookmark and Share
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
   Â© 2012
Netgains Logo